Cite
MLA Citation
T Anders Olsen et al.. “223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A133. http://access.bl.uk/ark:/81055/vdc_100144730569.0x000004